Saint Louis, Missouri

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Epilepsy2 trials
• Parkinson disease1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• AbbVie3 trials

Closed trials

• Terminated

  An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

  NCT04686786· Phase 2· AbbVie· Source

• Completed

  Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)

  NCT04542499· Phase 3· AbbVie· Source

• Completed

  A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

  NCT04244175· Phase 2· AbbVie· Source